Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Ajay Kirtane and Timothy Henry.
Ajay Kirtane
Connection Strength
1.007
Timothy Henry
  1. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020 08; 96(2):336-345.
    View in: PubMed
    Score: 0.220
  2. Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol. 2020 09 15; 76(11):1375-1384.
    View in: PubMed
    Score: 0.220
  3. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI. J Am Coll Cardiol. 2020 05 12; 75(18):2372-2375.
    View in: PubMed
    Score: 0.055
  4. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents. Circ Cardiovasc Interv. 2018 11; 11(11):e006243.
    View in: PubMed
    Score: 0.050
  5. Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
    View in: PubMed
    Score: 0.049
  6. Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents. Am Heart J. 2018 11; 205:77-86.
    View in: PubMed
    Score: 0.049
  7. Platelet Reactivity and Risk of Ischemic Stroke After Coronary Drug-Eluting Stent Implantation: From the ADAPT-DES Study. JACC Cardiovasc Interv. 2018 07 09; 11(13):1277-1286.
    View in: PubMed
    Score: 0.048
  8. Bleeding Severity After Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2018 03; 11(3):e005542.
    View in: PubMed
    Score: 0.047
  9. Sex differences in the effect of diabetes mellitus on platelet reactivity and coronary thrombosis: From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study. Int J Cardiol. 2017 Nov 01; 246:20-25.
    View in: PubMed
    Score: 0.046
  10. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
    View in: PubMed
    Score: 0.045
  11. Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study). Am J Cardiol. 2017 Sep 15; 120(6):917-923.
    View in: PubMed
    Score: 0.045
  12. Outcomes After Successful Percutaneous Coronary Intervention of Calcified Lesions Using Rotational Atherectomy, Cutting-Balloon Angioplasty, or Balloon-Only Angioplasty Before Drug-Eluting Stent Implantation. J Invasive Cardiol. 2017 Nov; 29(11):378-386.
    View in: PubMed
    Score: 0.045
  13. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents). Circ Cardiovasc Interv. 2017 02; 10(2).
    View in: PubMed
    Score: 0.044
  14. Two-year outcomes after percutaneous coronary intervention of calcified lesions with drug-eluting stents. Int J Cardiol. 2017 Mar 15; 231:61-67.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.